Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cooperative Allosteric Transitions

Cooperative Allosteric Transitions

Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...

EDTA: Conditional Formation Constant

EDTA: Conditional Formation Constant

Each EDTA molecule has six binding sites: four carboxyl groups and two amino groups. The fully protonated form of EDTA is represented as H6Y2+. However, it can exist in different forms, H5Y+, H4Y, H3Y−, H2Y2−, and HY3−, depending on the pH of the solution. In very basic solutions with pH > 10.17, the fully deprotonated form, Y4−, is the predominant species that readily complexes with metal ions in a 1:1 ratio.
For the equilibrium reaction of the metal with the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Context-Aware Hydrophobicity Modeling: HydroMap and FastHydroMap.

bioRxiv : the preprint server for biology·2026

Same author

Disentangling Intrachain Folding from Interchain Assembly through Multidimensional Visualization.

The journal of physical chemistry. B·2026

Same author

Good Practices for Simulation Studies Published in <i>The Journal of Physical Chemistry B</i>.

The journal of physical chemistry. B·2026

Same author

The Seasons of a Career in Physical Chemistry.

ACS physical chemistry Au·2026

Same author

The Seasons of a Career in Physical Chemistry: Olivia Harper Wilkins.

ACS physical chemistry Au·2026

Same author

The Seasons of a Career in Physical Chemistry: Rajarshi Chakrabarti.

The journal of physical chemistry. B·2026

Same journal

Predicting Nirmatrelvir Resistance in SARS-CoV-2 M<sup>pro</sup> Mutants with an Integrated Computational Framework.

The journal of physical chemistry. B·2026

Same journal

From Cation Solvation to Anion Coordination: Lewis-Acidic Boranes Enable Halide Salt Electrolytes.

The journal of physical chemistry. B·2026

Same journal

In Vitro-Prepared A30P Alpha-Synuclein Fibrils Adopt the Conserved and Disease-Relevant Greek Key Fold.

The journal of physical chemistry. B·2026

Same journal

Metastructure Analysis of Self-Assembled Nanocubes with Different Equatorial Methyl Groups Based on Molecular Dynamics Simulations.

The journal of physical chemistry. B·2026

Same journal

A Cocoordinated <sup>1</sup>H Internal Reference Quantifies Proton-Exchange Bias in Coordinated-Water Diffusion.

The journal of physical chemistry. B·2026

Same journal

Unveiling Electrolyte-Dependent Coordination Site Dynamics for Redox Mediator Design in Lithium-O<sub>2</sub> Batteries: Exchange vs Rearrangement.

The journal of physical chemistry. B·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Mar 31, 2026

In Vitro Assay for Studying the Aggregation of Tau Protein and Drug Screening

In Vitro Assay for Studying the Aggregation of Tau Protein and Drug Screening

Published on: November 20, 2018

Tau Aggregation Propensity Engrained in Its Solution State.

Neil A Eschmann¹, Thanh D Do¹, Nichole E LaPointe¹

¹Department of Chemistry and Biochemistry and ‡Neuroscience Research Institute and Department of Molecular, Cellular and Developmental Biology, University of California at Santa Barbara , Santa Barbara, California 93106, United States.

The Journal of Physical Chemistry. B

|October 21, 2015

Summary

This summary is machine-generated.

Initial solution conditions critically influence tau protein aggregation. Subtle protein-solvent interactions, not just aggregation accelerators, dictate the propensity of tau peptide fragments to form fibrils.

More Related Videos

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein

Published on: January 2, 2015

Characterizing Individual Protein Aggregates by Infrared Nanospectroscopy and Atomic Force Microscopy

Characterizing Individual Protein Aggregates by Infrared Nanospectroscopy and Atomic Force Microscopy

Published on: September 12, 2019

Related Experiment Videos

Last Updated: Mar 31, 2026

In Vitro Assay for Studying the Aggregation of Tau Protein and Drug Screening

In Vitro Assay for Studying the Aggregation of Tau Protein and Drug Screening

Published on: November 20, 2018

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein

Published on: January 2, 2015

Characterizing Individual Protein Aggregates by Infrared Nanospectroscopy and Atomic Force Microscopy

Characterizing Individual Protein Aggregates by Infrared Nanospectroscopy and Atomic Force Microscopy

Published on: September 12, 2019

Area of Science:

Biochemistry
Protein aggregation
Neurodegenerative diseases

Background:

Pathological aggregation of tau protein is a hallmark of neurodegenerative diseases.
Understanding the early stages of tau aggregation is crucial for developing therapeutic strategies.

Purpose of the Study:

To investigate how initial solution conditions affect the conformational states and aggregation propensity of a tau peptide fragment.
To determine if early monomer/dimer populations and conformations influence downstream fibril formation.

Main Methods:

A spin-labeled tau peptide fragment (R2/G273C-SL) was used.
Techniques included transmission electron microscopy (TEM), thioflavin T (THT) fluorescence, ion mobility mass spectrometry (IMMS), electron paramagnetic resonance (EPR), and Overhauser dynamic nuclear polarization (ODNP).
Varying solution conditions included osmolytes (urea, TMAO) and different buffers (acetate, phosphate, water).

Main Results:

Solution conditions significantly altered early monomer/dimer populations and conformations.
These initial peptide characteristics dictated the subsequent fibril formation propensity.
Aggregation accelerators like heparin did not override the influence of initial solvent conditions.

Conclusions:

The balance between protein-protein and protein-solvent interactions in the initial solution is a critical determinant of tau fibril formation.
Early conformational states and populations of tau peptides are crucial for predicting aggregation outcomes.
Therapeutic interventions targeting early protein-solvent interactions may offer new avenues for treating tauopathies.